Français An interactive recruitment and job search tool!

Search results

Here are your search results for the keyword 837 glaxosmithkline inc

This role will be covering the following territory : GTA up to Barrie, with expectation of northern travel (Thunder Bay/Sudbury).

June 17, 2024 by 837 GlaxoSmithKline Inc.
null, null, ca

Some of your responsibilities will include responding to requests for in-depth, innovative scientific information in the field of hepatology, including the most recent findings from scientific conferences, the most recent publications in scholarly journals, and GSK's pipeline. GSK souscrit au princi

June 17, 2024 by 837 GlaxoSmithKline Inc.
Laval, Quebec, ca

Ce rôle couvrira le territoire suivant: Région du Grand Montréal ou rive-nord idéalement (ex.Laval, Rosemère, Vaudreuil, Terrebonne, etc.Accélérer l’accès aux médicaments en hématologie-oncologie grâce à une compréhension approfondie du paysage en hématologie-oncologie et des spécif

June 17, 2024 by 837 GlaxoSmithKline Inc.
null, null, ca

As a Medical Science Liaison (MSL) you will be responsible for applying your non-promotional medical acumen to ensure the safe and effective use of GSK’s products, through impactful scientific interactions and support of key external and internal stakeholders in alignment to the therapeuti

June 10, 2024 by 837 GlaxoSmithKline Inc.
null, null, ca

As a Medical Science Liaison (MSL) you will be responsible for applying your non-promotional medical acumen to ensure the safe and effective use of GSK’s products, through impactful scientific interactions and support of key external and internal stakeholders in alignment to the therapeuti

June 09, 2024 by 837 GlaxoSmithKline Inc.
null, null, ca

As a GSK medical science liaison (MSL), your role will function as a key scientific resource for Canadian Hematology/Medical Oncology specialists. Your three core responsibilities are: 1) responding to requests for in-depth, scientific information in the field of hematology malignancies; 2) discussi

June 05, 2024 by 837 GlaxoSmithKline Inc.
null, null, ca